Overall intro from CEO
The Synergist is an integral player on a global scale, embodying true collaboration that is cross-sectoral, cross-discipline, and cross-border. Our systemic approach is centered around ongoing meaningful collaboration in a bid to provide solutions to what we see as the big societal problems facing us today.
Our approach is holistic: We are not funding-driven or partner-driven - we believe in our causes and invest in them on a long-term strategic basis, mobilising our people, partners - and resources to bring stakeholders together in a purposeful way to make a tangible systemic impact. Collaboration is not simply a meeting or phone call every few months or a one-off projects - it means truly working together towards a common vision and committing to seeing it become a reality. This ethos of co-creation is embedded in our mission and underpins every issue we are passionate about. The ultimate goal is bigger than any one player.
Through our expertise, skills, methodologies, and tools we have managed to galvanise many projects - for example, the precision medicine discussion group has reached new heights since our involvement, as we have launched FT3 with 19 members and seek to ensure tangible outcomes, achieving real results. Our tried and tested methodology allows us to move faster and more efficiently from the incubation phase, condensing what used to be 18 months to two years into just two to three months. We see fragmented effects and work on the bigger picture to harmonise, standardise and energise, turning a collective vision into a collective impact.
The Synergist employs unique skill sets, project management tools and methodologies, and software, all underpinned by a very different mindset. The various elements in this critical toolbox have been honed in the seven years since our inception and are now being used globally as we seek real change.
A prime example is our major project PFMD. Having recently reached the five-year milestone, we see it now at a turning point as it grows to encompass devices, digital health, and broader health systems. Having fully embedded patient engagement in drug development via our suite of tools we can no longer afford to have other parts of the ecosystem immature, each element must be equally patient-centric by working WITH patients. Once again our holistic approach is at the fore. We also want to go further in terms of its reach, scaling up as we expand into Asia and even further afield in 2021 as we share the knowledge and assets in patient engagement that we have accumulated. Our work in patient engagement is far from finished but we can be proud of the progress we have made.
Internally we continue to grow and expand, adding fresh talent to our quality team and enabling ourselves to develop even more projects and plans for the future, capitalising on our success and achievements. We have a demonstrated ability to create effective networks within niche ecosystems but in 2021 we will work on building even deeper connections between diverse actors as our network grows ever bigger and more influential.
Collective programs are the only way we will be able to solve collective issues. The Synergist with its seven years of experience and tried and tested methodology, is now looking to the future as we seek to replicate and scale our achievements in the health domain, building on these successes as we address other major societal issues. We look forward to 2021 with great excitement.
Executive Director
